Advertisement
ResearchIn-Press PreviewCardiologyVascular biology
Open Access | 10.1172/JCI186673
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by He, D. in: JCI | PubMed | Google Scholar
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by Ma, J. in: JCI | PubMed | Google Scholar
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by Zhou, Z. in: JCI | PubMed | Google Scholar
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by Qi, Y. in: JCI | PubMed | Google Scholar
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by Lian, Y. in: JCI | PubMed | Google Scholar
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by Wang, F. in: JCI | PubMed | Google Scholar
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by
Yin, H.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by Zhang, H. in: JCI | PubMed | Google Scholar
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by Zhang, T. in: JCI | PubMed | Google Scholar
1Department of Cardiology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China
2Department of Biomedical Sciences, Tung Biomedical Science Center, The Shen, College of Biomedicine, City University of Hong Kong, Hong Kong, China
Find articles by
Huang, H.
in:
JCI
|
PubMed
|
Google Scholar
|
Published March 11, 2025 - More info
Osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs) has been recognized as the principal mechanism underlying vascular calcification (VC). Runt-related transcription factor 2 (RUNX2) in VSMCs plays a pivotal role because it constitutes an essential osteogenic transcription factor for bone formation. As a key DNA demethylation enzyme, ten-eleven translocation 2 (TET2) is crucial in maintaining the VSMC phenotype. However, whether TET2 involves in VC progression remains elusive. Here we identified a substantial downregulation of TET2 in calcified human and mouse arteries, as well as human primary VSMCs. In vitro gain- and loss-of function experiments demonstrated TET2 regulated VC. Subsequently, in vivo knockdown of TET2 significantly exacerbated VC in both vitamin D3 and adenine-diet-induced chronic kidney disease (CKD) mice models. Mechanistically, TET2 binds to and suppresses the activity of the P2 promoter within the RUNX2 gene, whereas an enzymatic loss-of-function mutation of TET2 has a comparable effect. Furthermore, TET2 forms a complex with histone deacetylases 1/2 (HDAC1/2 ) to deacetylate H3K27ac on the P2 promoter, thereby inhibiting its transcription. Moreover, SNIP1 is indispensable for TET2 to interact with HDAC1/2 to exert inhibitory effect on VC, and knockdown of SNIP1 accelerated VC in mice. Collectively, our findings imply that TET2 might serve as a potential therapeutic target for VC.